Navigation Links
Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
Date:5/27/2008

KENILWORTH, N.J., May 27 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that Janet M. Barth has been appointed vice president, investor relations, effective immediately.

In this role, Barth will be responsible for developing, implementing and continually improving a comprehensive global investor relations program for Schering-Plough. She will lead the formulation and execution of external and internal investor communications plans to support Schering-Plough's business objectives. She also will partner with the company's senior management team on matters pertaining to the investment community and individual shareholders.

Barth reports to Alex Kelly, group vice president, global communications and investor relations. She assumes the investor relations responsibilities that were previously fulfilled by Kelly, who was named to his current expanded role in October 2007.

Barth most recently served as senior vice president, investor relations and corporate communications, for Adams Respiratory Therapeutics, which was a newly public specialty pharmaceutical company. In that role, she established, developed and directed comprehensive investor relations and corporate communications programs for the company prior to its acquisition by Reckitt Benckiser in January 2008.

Previously, Barth was employed for 14 years by Schering-Plough, where she held various positions of increasing responsibility, including that of director, investor relations. Barth holds a Bachelor of Arts degree in policy and management studies from Dickinson College, Carlisle, Pa., and a Master of Business Administration degree from Seton Hall University, South Orange, N.J. She joined the National Investor Relations Institute (NIRI) in 1996 and currently is a member of NIRI's New York and Virtual Chapters. Barth completed a 12-month leadership development program with Women Unlimited LEAD (Leadership Education and Development) in 2005.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription and consumer products as well as to animal health products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
2. Schering-Plough Announces Pricing of Senior Notes Offering
3. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Schering-Plough Completes Acquisition of Organon BioSciences
6. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
9. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
10. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
11. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... ... October 11, 2017 , ... At its ... announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist of ... been selected for membership in ARCS Alumni Hall of Fame . ASTER ...
(Date:10/11/2017)... BALTIMORE, Md. (PRWEB) , ... October 11, 2017 ... ... for digital pathology, announced today it will be hosting a Webinar titled, “Pathology ... of  Advanced Pathology Associates , on digital pathology adoption best practices and how ...
(Date:10/11/2017)... ... October 11, 2017 , ... A ... pregnancy rates in frozen and fresh in vitro fertilization (IVF) transfer ... age to IVF success. , After comparing the results from the fresh and ...
(Date:10/10/2017)... PA (PRWEB) , ... October 10, 2017 , ... ... City Science Center’s FirstHand program has won a US2020 STEM Mentoring Award. Representatives ... the award for Excellence in Volunteer Experience from US2020. , US2020’s mission is ...
Breaking Biology Technology:
(Date:10/4/2017)... Oct. 4, 2017  GCE Solutions, a global clinical research organization ... document anonymization solution on October 4, 2017. Shadow is designed to ... comply with policy 0070 of the European Medicines Agency (EMA) in ... ... ...
(Date:7/20/2017)... , July 20, 2017 Delta (NYSE: DAL ) ... any Delta aircraft at Reagan Washington National Airport (DCA). ... Delta launches biometrics to board ... Delta,s biometric boarding ... Club is now integrated into the boarding process to allow eligible ...
(Date:6/14/2017)... IBM ) is introducing several innovative partner startups at ... between startups and global businesses, taking place in ... startups will showcase the solutions they have built with IBM ... France is one of the most ... increase in the number of startups created between 2012 and ...
Breaking Biology News(10 mins):